ALLEI Stock Analysis: Alleima (publ) | ST
Steel | ST, Sweden | Market Cap: 22.612m SEK | 12M Return: 20.4% | SE0017615644 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 28.3M
EPS Trend: -91.8%
Qual. Beats: 0
Rev. Trend: -92.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 4.2 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Alleima AB is a Sweden-based manufacturer of stainless steel, specialty alloys, medical wires and components, and electric heating systems. Its three divisions-Tube, Kanthal and Strip-serve customers in energy, industrial, medical, transportation, mining and construction markets.
Its products include tubes and strip steel for demanding applications such as chemical processing, aerospace, nuclear power and renewable energy. Specialty steel and alloy suppliers provide materials designed for specific requirements such as corrosion resistance, heat tolerance and precision. Founded in 1862, Alleima is headquartered in Sandviken, Sweden.
- Oil-and-gas project demand drives Tube orders and revenue
- Specialty-alloy mix and input costs shape margins
- Medical, nuclear and energy-transition demand supports growth offsetting industrial cyclicality
| Net Income: 1.03b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.48 > 1.0 |
| NWC/Revenue: 45.48% < 20% (prev 41.88%; Δ 3.61% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.81b > Net Income 1.03b |
| Net Debt (-118.0m) to EBITDA (2.50b): -0.05 < 3 |
| Current Ratio: 2.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (250.0m) vs 12m ago -0.34% < -2% |
| Gross Margin: 21.30% > 18% (prev 19.61%; Δ 1.68% > 0.5%) |
| Asset Turnover: 78.74% > 50% (prev 84.69%; Δ -5.95% > 0%) |
| Interest Coverage Ratio: 11.57 > 6 (EBIT TTM 1.48b / Interest Expense TTM 128.0m) |
| A: 0.35 (Total Current Assets 12.8b - Total Current Liabilities 4.50b) / Total Assets 23.6b |
| B: 0.69 (Retained Earnings 16.3b / Total Assets 23.6b) |
| C: 0.06 (EBIT TTM 1.48b / Avg Total Assets 23.1b) |
| D: 2.80 (Book Value of Equity 17.4b / Total Liabilities 6.20b) |
| Altman-Z'' = 7.94 = AAA |
| DSRI: 1.18 (Receivables 3.85b/3.45b, Revenue 18.2b/19.2b) |
| GMI: 0.92 (GM 19.61% / 21.30%) |
| AQI: 0.98 (AQ_t 0.10 / AQ_t-1 0.11) |
| SGI: 0.95 (Revenue 18.2b / 19.2b) |
| TATA: -0.03 (NI 1.03b - CFO 1.81b) / TA 23.6b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of November 13, 2026, the stock is trading at SEK 96.10 with a total of 313,684 shares traded. Over the past week, the price has changed by +4.34%, over one month by -16.29%, over three months by -16.80% and over the past year by +20.41%.
Current recommended Stop Loss: 91.50 (which is 4.8% or 1.3 ATR below the current price).
Alleima (publ) has no consensus analysts rating.
P/E Trailing = 21.9296
P/E Forward = 18.315
P/S = 1.2409
P/B = 1.3264
Revenue TTM = 18.2b SEK
EBIT TTM = 1.48b SEK
EBITDA TTM = 2.50b SEK
Long Term Debt = 871.0m SEK (from longTermDebt, last quarter)
Short Term Debt = 141.0m SEK (from shortTermDebt, last quarter)
Debt = 1.43b SEK (from shortLongTermDebtTotal, last quarter) + Leases 417.0m
Net Debt = -118.0m SEK (calculated: Debt 1.43b - CCE 1.55b)
Enterprise Value = 22.5b SEK (22.6b + Debt 1.43b - CCE 1.55b)
Interest Coverage Ratio = 11.57 (Ebit TTM 1.48b / Interest Expense TTM 128.0m)
EV/FCF = 29.10x (Enterprise Value 22.5b / FCF TTM 773.0m)
FCF Yield = 3.44% (FCF TTM 773.0m / Enterprise Value 22.5b)
FCF Margin = 4.24% (FCF TTM 773.0m / Revenue TTM 18.2b)
Net Margin = 5.67% (Net Income TTM 1.03b / Revenue TTM 18.2b)
Gross Margin = 21.30% ((Revenue TTM 18.2b - Cost of Revenue TTM 14.3b) / Revenue TTM)
Gross Margin QoQ = 20.13% (prev 27.02%)
Tobins Q-Ratio = 0.95 (Enterprise Value 22.5b / Total Assets 23.6b)
Interest Expense / Debt = 8.96% (Interest Expense 128.0m / Debt 1.43b)
Taxrate = 25.95% (362.0m / 1.40b)
NOPAT = 1.10b (EBIT 1.48b * (1 - 25.95%))
Current Ratio = 2.84 (Total Current Assets 12.8b / Total Current Liabilities 4.50b)
Debt / Equity = 0.08 (Debt 1.43b / totalStockholderEquity, last quarter 17.4b)
Debt / EBITDA = -0.05 (Net Debt -118.0m / EBITDA 2.50b)
Debt / FCF = -0.15 (Net Debt -118.0m / FCF TTM 773.0m)
Total Stockholder Equity = 16.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.46% (Net Income 1.03b / Total Assets 23.6b)
RoE = 6.11% (Net Income TTM 1.03b / Total Stockholder Equity 16.9b)
RoCE = 8.33% (EBIT 1.48b / Capital Employed (Equity 16.9b + L.T.Debt 871.0m))
RoIC = 5.99% (NOPAT 1.10b / Invested Capital 18.3b)
WACC = 8.24% (E(22.6b)/V(24.0b) * Re(8.34%) + D(1.43b)/V(24.0b) * Rd(8.96%) * (1-Tc(0.26)))
Discount Rate = 8.34% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -8.47 | Cagr: -0.15%
[DCF] Terminal Value 77.97% ; FCFF base≈718.2m ; Y1≈823.3m ; Y5≈1.21b
[DCF] Fair Price = 73.33 (EV 18.2b - Net Debt -118.0m = Equity 18.4b / Shares 250.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -91.75 | EPS CAGR: -19.70% | SUE: -0.78 | # QB: 0
Revenue Correlation: -92.38 | Revenue CAGR: -4.44% | SUE: -0.56 | # QB: 0
EPS current Quarter (2027-03-31): EPS=1.40 | Chg30d=+4.87% | Revisions=+40% | Analysts=2
EPS current Year (2026-12-31): EPS=4.37 | Chg30d=-11.00% | Revisions=-29% | GrowthEPS=-5.4% | GrowthRev=-1.1%
EPS next Year (2027-12-31): EPS=5.82 | Chg30d=-2.15% | Revisions=+57% | GrowthEPS=+33.3% | GrowthRev=+6.3%
[Analyst] Revisions Ratio: +31% (up=7, down=3)